PYC logo

Physiomics Share Price

Symbol: AIM:PYCMarket Cap: UK£1.4mCategory: Pharmaceuticals & Biotech

PYC Share Price Performance

PYC Community Fair Values

    Recent PYC News & Updates

    No updates

    Physiomics Plc Key Details

    UK£542.6k

    Revenue

    UK£1.2m

    Cost of Revenue

    -UK£663.1k

    Gross Profit

    -UK£28.8k

    Other Expenses

    -UK£634.4k

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.0021
    Gross Margin
    -122.22%
    Net Profit Margin
    -116.92%
    Debt/Equity Ratio
    0%

    Physiomics Plc Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About PYC

    Founded
    2001
    Employees
    11
    CEO
    Peter Sargent
    WebsiteView website
    www.physiomics.co.uk

    Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.

    U.K. Market Performance

    • 7 Days: 2.1%
    • 3 Months: 8.5%
    • 1 Year: 8.4%
    • Year to Date: 9.0%
    Over the past 7 days, the market has risen 2.1% with the Consumer Staples sector contributing the most to the gain. As for the past 12 months, the market is up 8.4%. Earnings are forecast to grow by 15% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading